Metformin Hydrochloride Amarox (Metformin Hydrochloride)

Metformin works by activating AMP‑activated protein kinase, which reduces hepatic glucose production and increases insulin‑mediated glucose uptake in muscle and fat tissue. This dual action lowers circulating glucose without directly stimulating insulin secretion.

The dose of Metformin Hydrochloride Amarox is individualized by the prescribing clinician based on the patient’s renal function, glycaemic targets and tolerability. The prescriber determines the appropriate strength, frequency and titration schedule.

Safety data in pregnancy are limited; Metformin may be used when the potential benefit outweighs the risk, but the decision should be made by a qualified healthcare professional. During breastfeeding, the drug is excreted in milk in small amounts, and a clinician should assess the risk‑benefit ratio.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line biguanide that lowers glucose without causing hypoglycaemia when used alone, unlike sulfonylureas which stimulate insulin release. It also promotes modest weight loss, whereas some other agents may cause weight gain. Its safety profile and cardiovascular benefits make it a preferred initial therapy for many patients.

Store the product at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the tablets out of reach of children and do not use after the expiry date printed on the label.

Metformin Hydrochloride Amarox is taken orally, usually with meals to minimise gastrointestinal upset. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake or acute medical illness. Prompt medical attention is required if symptoms such as unexplained fatigue, muscle pain or rapid breathing develop.

Metformin should be avoided in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or in patients with conditions that predispose to hypoxia such as severe heart failure or recent myocardial infarction.